The metabolic chiral inversion and dispositional enantioselectivity of the 2-arylpropionic acids and their biological consequences

Biochemical Pharmacology

Volumn 37, Issue 1, 1988, Pages 105-114

  Caldwell, John ^a   Hutt, Andrew J ^b   Fournel Gigleux, Sylvie ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF BRIGHTON   (United Kingdom)

^c UNIVERSITÉ DE LORRAINE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARYLPROPIONIC ACID; UNCLASSIFIED DRUG;

CHIRALITY; DRUG METABOLISM; PRIORITY JOURNAL;

ANIMAL; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; HUMAN; KIDNEY; MOLECULAR CONFORMATION; PHENYLPROPIONATES; PROTEIN BINDING; STEREOISOMERISM;

EID: 0023835819     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-2952(88)90762-9     Document Type: Article

References (53)

1. Biological implications of the metabolic chiral inversion of 2-arylpropionic acid non-steroidal anti-inflammatory drugs
2. The metabolic chiral inversion of 2-arylpropionic acids. A novel route with pharmacological consequences
3. The importance of stereochemistry in the clinical pharmacokinetics of the 2-arylpropionic acid non-steroidal anti-inflammatory drugs
4. The Chromatographic analysis of enantiomers in drug metabolism studies
5. Stereoselectivity of bioactive agents: general aspects
6. Pharmacological differences between the optical isomers of ibuprofen: evidence for the metabolic inversion of the (−)-isomer
7. Antagonism of slow reacting substances in anaphylaxis (SRS-A9) and other spasmogens on the guinea pig tracheal chain by hydratropic acids and their effect on anaphylaxis
8. Biological activity of indoprofen and its optical isomers
9. Inhibition of prostaglandin synthetase by pirprofen, studies with sheep seminal vesicle enzyme
10. Relationship between inhibition of prostaglandin synthesis and drug efficacy: support for the current theory on mode of action of aspirin-like drugs
11. Stereoisomeric relationships among anti-inflammatory activity, inhibition of platelet aggregation and inhibition of prostaglandin synthetase
12. Anti-inflammatory and analgesic effects of fenoprofen
13. Stereoselective inversion of (R)-fenoprofen to (S)-fenoprofen in humans
14. Non-steroidal anti-inflammatory agents. I. 6-Substituted 2-naphthylacetic acids
15. The metabolic chiral inversion of 2-phenylpropionic acid in rat, mouse and rabbit
16. The determination of optical isomers of 2-[3-(2-chlorophenoxyphenyl)]-propionic acid in rat plasma by high performance liquid chromatography
17. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs IV. Ketoprofen disposition
18. Optical inversion of (2R)- to (2S)-isomers of 2-[4-(2-oxocyclopentylmethyl)-phenyl]propionic acid (Loxoprofen), a new anti-inflammatory agent, and its monohydroxy metabolites in the rat
19. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs III. Fenoprofen disposition
20. Disposition of thioxaprofene: kinetics of the stereoisomers
21. Optical isomerization mechanism of R(−)-hydratropic acid derivatives
22. The Stereoselective uptake of ibuprofen enantiomers into adipose tissue
23. The participation of ethyl 4-benzyloxy-benzoate (BRL 10894) and other aryl-substituted acids in glycerolipid metabolism
24. Stereoselective disposition of ibuprofen enantiomers in man
25. Application of a radial compression column to the high-performance liquid Chromatographie separation of the enantiomers of some 2-arylpropionic acids as their diastereoisomeric S-1-(naphthen-1-yl)ethylamides
26. Enantiomeric analysis of 2-phenylpropionic acid NSAIDs in biological fluids by high-performance liquid chromatography
27. Species differences in metabolism of sodium 2-[4-(2-oxocyclopentylmethyl)phenyl]propionate dihydrate (Loxoprofen sodium), a new anti-inflammatory agent
28. Stereoselective disposition of hydratropic acid in rat
29. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs I. 2-Phenylpropionic acid disposition
30. Pharmacokinetics of the enantiomers of indoprofen in man
31. Pharmacokinetics of the enantiomers of tiaprofenic acid in humans
32. Some biological properties of 2-(4-isobutylphenyl)propionic acid
33. The metabolism of ibuprofen
34. Enzymatic inversion at saturated carbon: Nature and mechanism of the inversion of R(−)p-isobutylhydratropic acid
35. Isomeric inversion of ibuprofen (R)-enantiomer in humans
36. Stereospecific assay of ibuprofen and its metabolites
37. Metabolic disposition of 6-chloro-5-cyclohexyl-1-indancarboxylic acid (TA1-284) a new non-steroidal anti-inflammatory agent in Rhesus monkeys
38. Structural determination of rat urinary metabolites of sodium 2-[4-(2-oxocyclopentylmethyl)phenyl]propionate dihydrate (Loxoprofen sodium) a new anti-inflammatory agent
39. Inhibition of prostaglandin synthesis by sodium 2-[4-(2-oxocyclopentylmethyl)phenyl]propionate dihydrate (CS-600), a new anti-inflammatory drug, and its active metabolite in vitro and in vivo
40. Column liquid chromatography for the simultaneous determination of the enantiomers of loxoprofen sodium and its metabolites in human urine
41. Pharmacokinetics and metabolism of non-steroidal anti-inflammatory drugs
42. Direct stereospecific determination of benoxaprofen glucuronides: influence of probenecid on the urinary excretion rates of the diastereoisomeric glucuronides
43. A circular dichroic investigation of the binding of fenoprofen, 2-(3-phenoxyphenyl)propionic acid to human serum albumin
44. Resolution of (±)-α-(3-benzoylphenyl)propionic acid (Ketoprofen) and diastereomeric interaction of its enantiomers with some biological systems
45. The assay and in vitro binding of the enantiomers of ibuprofen
46. Enantioselective disposition of 2-arylpropionic acid nonsteroidal anti-inflammatory drugs II. 2-Phenylpropionic acid protein binding
47. Mechanisms of gastric contrasted with intestinal damage by non-steroidal anti-inflammatory drugs
48. Stereochemistry—a basis for sophisticated nonsense in clinical pharmacokinetics
49. Stereoselectivity of bioactive xenobiotics. A pre-Pasteur attitude in medicinal chemistry, pharmacokinetics and clinical pharmacology